Page last updated: 2024-08-21

thiazoles and taxane

thiazoles has been researched along with taxane in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bollbuck, B; Downing, KH; Fojo, T; Giannakakou, P; Gussio, R; Nicolaou, KC; Nogales, E; Poy, G; Sackett, D; Zaharevitz, D1
Cristofanilli, M; Gradishar, WJ; Helenowski, I; Jain, S; Rademaker, A; Santa-Maria, CA; Shah, AN; Siziopikou, K1
Bai, Y; Gang, X; Huang, H; Karnes, RJ; Lv, Q; Ma, L; Pan, Y; Wu, Q; Yan, Y; Yang, Y; Zhang, J1

Trials

1 trial(s) available for thiazoles and taxane

ArticleYear
Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy.
    Breast cancer research and treatment, 2018, Volume: 171, Issue:2

    Topics: Ado-Trastuzumab Emtansine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Bridged-Ring Compounds; Female; Humans; Kaplan-Meier Estimate; Maximum Tolerated Dose; Maytansine; Middle Aged; Neoplasm Staging; Phosphatidylinositol 3-Kinases; Receptor, ErbB-2; Retreatment; Taxoids; Thiazoles; Trastuzumab; Treatment Outcome

2018

Other Studies

2 other study(ies) available for thiazoles and taxane

ArticleYear
A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Mar-14, Volume: 97, Issue:6

    Topics: Alkaloids; Antineoplastic Agents; Bridged-Ring Compounds; Diterpenes; Docetaxel; Drug Resistance, Neoplasm; Epothilones; Epoxy Compounds; Humans; Inhibitory Concentration 50; Models, Chemical; Models, Molecular; Mutation; Paclitaxel; Protein Conformation; Structure-Activity Relationship; Taxoids; Thiazoles; Tubulin; Tumor Cells, Cultured

2000
Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer.
    Theranostics, 2019, Volume: 9, Issue:17

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cell Line, Tumor; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Forkhead Box Protein O1; Humans; Male; Mice; Mice, Nude; Mice, SCID; Mutation; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; PTEN Phosphohydrolase; Taxoids; Tetrazolium Salts; Thiazoles

2019